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Soluble extracts of the methanogenic archaeon, Methanosurcina thermophilu TM-l, contained a divalent metal ion-stimulated protein-serine 
phosphatase activity. This activity was sensitive to micromolar concentrations of okadaic acid, microcystin-LR, or calyculin A, three compounds 
thought to be highly specific inhibitors of the type 1/2A/2B genetic superfamily of eukaryotic protein-serine/threonine phosphatases. The observa- 
tion that each of these three chemically unrelated compounds inhibited this archaeal protein phosphatase activity suggests the existence of structural 
homology, and perhaps even common genetic ancestry, with the type 1/2A/2B superfamily of protein-serine/threonine phosphatases found in 
eukaryotic organisms. 
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1. INTRODUCTION 
The modulation of protein function by phosphoryla- 
tion and dephosphorylation is an ubiquitous regulatory 
phenomenon employed by organisms of all morpholo- 
gies, ancestries, and habitats. Despite this universality, 
the lack of molecular parallels or links between protein 
kinases or protein phosphatases from eukaryotic and 
prokaryotic organisms at either the structural, func- 
tional, or immunological level (reviewed in [l]) has long 
been regarded as evidence that the origin and evolution 
of the protein phosphorylation networks within each of 
the individual phylogenetic domains were unique. Re- 
cently, however, several observations have come to light 
suggesting that the lines of descent of the protein ki- 
nases and protein phosphatases in eukaryotic and bac- 
terial organisms may not have been so completely segre- 
gated as previously supposed [2-61. 
We have extended the search for molecular parallels 
to the third phylogenetic domain in nature, the 
Archaea. Herein we report that extracts of the 
archaeon, Methanosarcina thermophila TM-l [7], con- 
tained a protein-serine phosphatase activity that was 
sensitive to a set of inhibitors widely thought to specif- 
ically target the protein phosphatases of the type 1/2A/ 
2B genetic superfamily in eukaryotes: okadaic acid, mi- 
crocystin-LR, and calyculin A [8,9]. To our knowledge, 
this represents the first instance in which sensitivity to 
these compounds has been observed in a protein phos- 
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Soluble extract, 10 ml, was thawed and loaded onto a l&l5 ml 
column of DE-52 cellulose equilibrated in 10 mM 2-(N-mor- 
pholino)ethanesulfonic a id (MES), pH 6.5. The column was washed 
with 10 mM MES, pH 6.5, then developed with a linear salt gradient 
of 50 ml each of 10 mM MES, pH 6.5, and 10 mM MES, pH 6.5, 
containing 400 mM KCl. Fractions, 2 ml each, were collected and 
assayed for protein phosphatase activity as described below. Active 
fractions were pooled to give the DE-52 fraction, which was then 
divided into aliquots and stored frozen at -20°C. 
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phatase from a prokaryotic (i.e. archaeal or bacterial) 
organism of any kind. 
2. MATERIALS AND METHODS 
2.1. Materials 
Purchased materials included the ammonium salt of okadaic acid 
(LC Services Corp., Wobum, MA); calyculin A and microcystin-LR 
(Gibco, Bethesda Research Laboratories, Gaithersburg, MD); ly- 
sozyme, maleic anhydride, and dioxane (Sigma, St. Louis, MO); and 
DNase I (Boehringer-Mannheim, Indianapolis, IN). Heat-stable pro- 
tein phosphatase inhibitor-2 was the gift of Prof. Shirish Shenolikar 
of Duke University. All other materials were from previously listed 
sources [lo]. 
2.2. Growth of organism and preparation of extracts 
Cells of Methanosarcina thermophila strain TM-l [7] were grown 
anaerobically on acetate in a 10 liter pH auxostat, harvested using a 
continuous-flow centrifuge, and frozen in liquid nitrogen as described 
by Sowers et al. [ll]. Soluble extracts were prepared anaerobically as 
described previously [12] with the following modifications: (i) the 
breakage buffer consisted of 50 mM MOPS, pH 6.8, containing 10 
mM MgCl,, 10% (v/v) glycerol, and 0.1 mg/ml DNase I, (ii) the dis- 
rupted cells were spun at 4,200 x g instead of 27,000 x g, and (iii) the 
resulting supematant was dialyzed vs. 10 mM MES, pH 6.5. Aliquots 
of soluble extract were stored frozen at -2O’C prior to use. 
2.3. Preparation of DE-52 fraction 
Volume 33 1, number 3 FEBSLETTERS October 1993 
2.4. Protein and phosphate analyses 
Protein concentrations were determined as described by Bradford 
[13] using pre-mixed reagent and a standardized solution of bovine 
serum albumin from Pierce (Rockford, IL). Inorganic phosphate was 
identified by thin-layer electrophoresis or extraction into organic sol- 
vents as a molybdic acid complex as previously described [lo]. 
2.5. Preparation of 3zP-labeled phosphoproteins and phosphopeptiaks 
Casein and mixed histones were phosphorylated using [r-‘*P]ATP 
and the catalytic subunit of the CAMP-dependent protein kinase essen- 
tially as described previously [lo]. Glycogen phosphorylase a was 
prepared using [Y-~~P]ATP and the components of the Protein Phos- 
phatase Assay System from Gibco, Bethesda Research Laboratories, 
following the manufacturer’s protocols. Reduced, carboxy- 
amidomethylated and maleylated lysozyme was prepared and subse- 
quently phosphorylated using [y-‘*]ATP and recombinant mouse lyn 
protein tyrosine kinase, as described by Sheng and Charbonneau [14]. 
The E. coli strain expressing the recombinant lyn protein-tyrosine 
kinase was the generous gift of Prof. Marietta Harrison of Purdue 
University. 
2.6. Assay of protein phosphatase activity 
Protein phosphatase activity was assayed as previously described 
[lo]. Briefly, samples of protein phosphatase were incubated at 25°C 
in a volume of 30 ~1 containing 20 mM MES, pH 6.5,20 mM MnCl,, 
0.33 mg/ml BSA, and 24 PM casein-bound [‘2P]phosphate. Reaction 
was terminated, typically after an incubation period of 60 min, by the 
addition of 100~1 of 20% (w/v) trichloroacetic acid, mixed, centrifuged 
for 3 min in a microfuge at maximum speed, and 50 ~1 of the superna- 
tant liquid removed and counted for 32P radioactivity in 2.0 ml of 
Eco-Lume liquid scintillation cocktail. An identical procedure was 
used for the assay of protein phosphatase activity toward glycogen 
phosphorylase a and mixed histones with the exception that, for the 
last named, the trichloroacetic acid concentration was increased to 
32.5% (w/v). 
3. RESULTS 
Incubation of casein that had been phosphorylated 
using [Y-~‘P]ATP and the catalytic subunit of the 
CAMP-dependent protein kinase with soluble extracts 
from Methanosarcina thermophila TM-1 in the presence 
of the divalent metal ion, Mn*‘, resulted in the release 
trichloroacetic acid-soluble 32P radioactivity from 
phosphorylated casein. The reaction product was iden- 
tified as inorganic phosphate by comparing its migra- 
tion with that of genuine inorganic phosphate by thin- 
layer electrophoresis and by quantitatively extracting it 
into organic solvents as a molybdate complex (data not 
shown). We observed that soluble extracts also con- 
tained what appeared to be an endogenous inhibitor of 
this phosphocasein protein phosphatase activity. Since 
this inhibitory factor could be removed by ion-exchange 
chromatography on DE-52 cellulose, all of the experi- 
ments described below were performed using protein 
phosphatase that had been partially purified in this 
manner. 
In addition to Mn*+, protein phosphatase activity was 
stimulated by the addition of Ni*+ or Co*+ (Fig. 1). The 
addition of any second divalent metal ion in combina- 
tion with the most effective activator, Mn2+, produced 
no greater activation than was observed with Mn*’ 
alone (Fig. l), indicating that only a single type of diva- 
lent metal ion-stimulated protein phosphatase was pres- 
ent in these extracts. The chromatographic behavior of 
protein phosphatase activity on DE-52 ion-exchange 
columns was also consistent with the presence of a sin- 
gle type of divalent metal ion-stimulated protein phos- 
phatase (data not shown). A survey of a wide range of 
other potential activators and inhibitors revealed that 
none of these compounds was able to stimulate protein 
phosphatase activity significantly above the level pro- 
duced by divalent metal ions alone (Table I). 
In addition to casein, the archaeal protein phosphat- 
ase dephosphorylated glycogen phosphorylase a as well 
as mixed histones that had been phosphorylated by the 
catalytic subunit of the CAMP-dependent protein kinase 
(Fig. 2). No activity was observed toward RCM-ly- 
sozyme that was phosphorylated on tyrosine, suggest- 
ing that the enzyme may be phosphoserine- (and per- 
120 
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ADDITIONS 
Fig. 1. Stimulation of M. thermophila TM-l protein phosphatase activity by divalent metal ions. The DE-52 fraction, 39 pug, was assayed under 
standard conditions with the exception that the compounds listed were substituted for the usual activating divalent metal ion, Mn2’. Where present, 
the concentration of each metal ion was 20 mM and that of EDTA was 5 mM. All results are reported as the percentage of the activity observed 
with the most potent individual metal ion activator, Mn’+, plus S.E.M. The number of replicates for each measurement is shown in parentheses. 
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haps phosphothreonine-) specific. Protein phosphatase 
activity was insensitive to incubation with a wide range 
of sulfhydryl-modifying reagents, but could be com- 
pletely eliminated by treatment with diethylpyrocarbon- 
ate. Subsequent incubation of diethylpyrocarbonate- 
treated enzyme with hydroxylamine resulted in partial 
(approximately 20%) restoration of activity, indicating 
that this reagent acted, at least in part, through modifi- 
cation of a histidyl residue [15]. 
Protein phosphatase activity could be completely in- 
hibited by the divalent metal ions, Cd’+, Cu2+ or Zn” 
(Fig. 1). In addition, the broad-specificity protein phos- 
phatase inhibitors, sodium phosphate, sodium pyro- 
phosphate, and sodium fluoride, all inhibited archaeal 
protein phosphatase activity (Table I), as did the pro- 
tein phosphatase 1/2A/2B-specific inhibitors, okadaic 
acid, microcystin-LR, or calyculin A (Fig. 3). Inhibition 
by each of the latter three compounds was observed 
independent of the identity of the phosphoprotein used 
Table I 
Effect of potential activators and inhibitors on M. thermophila TM-l 
protein phosphatase 
Addition Concentration Activity (% control) 
None (control) 
CAMP 
cGMP 
1,4,5Jnositol 
trisphosphate 
Ca2+ plus calmodulin 
Spermine 
Spermidine 
Poly-L-lysine 
Poly-L-arginine 
Heparin 
Chondroitin sulfate 
NaF 
Tartrate 
Tetramisole 
p-Nitrophenylphosphate 
Sodium phosphate 
Sodium pyrophosphate 
Sodium orthovanadate 
Sodium molybdate 
/J-Glycerol phosphate 
Trifluoperazine 
ATP 
ADP 
AMP 
_ 100 
1mM 101 + 10 
1mM 123 + 16 
10j~M 126 f 16 
lmMand5pM 125f 7 
0.1 mg/ml 115 f 15 
0.1 mg/ml 113 f 14 
0.1 mg/ml 110 f 11 
0.1 mg/ml 95+ 6 
0.1 mg/ml 68k 17 
0.6 mg/ml 39f 3 
0.1 mg/ml 106 + 15 
50 mM 32 + 20 
10 mM 70+ 12 
1mM 131 + 28 
10 mM 80+ 18 
50 mM 9f 6 
10 mM 17i: 3 
10 mM Not detectable 
1mM 24+ 8 
0.1 mM 74f 3 
0.1 mM 94+ 7 
10 mM 116 f 18 
150 PM 124 f 21 
5mM 102 f 10 
5mM 81 f 15 
5mM 113 f 16 
The table summarizes the results of several individual experiments. In 
all cases the DE-52 fraction was assayed for activity under standard 
conditions with the exception that the compounds listed below were 
present at the indicated final concentrations. All results represent he 
average of three or more determinations and are reported as the 
percent of activity measured in the presence. of no added com- 
pounds k S.E.M. 
Time (min) 
Fig. 2. Comparative rate of dephosphorylation of histones, casein and 
phosphorylase a by M. thermophila TM-1 protein phosphatase. The 
DE-52 fraction, 40 pg, was assayed for activity toward the following 
phosphoprotein substrates: casein (o), mixed histones (o), and glyco- 
gen phosphorylase a (A). Standard assay conditions were employed 
with the exception that (i) the indicated compounds were substituted 
for the standard substrate, casein, and (ii) the concentration of the 
trichloroacetic acid solution used to terminate the assay was increased 
to 32.5% (w/v) to insure complete precipitation of the histones. All 
substrates were present at a final concentration of 1.7 PM protein- 
bound phosphate. Shown is the percentage of phosphate released from 
each substrate as a function of time. 
as substrate, indicating that they most likely were acting 
upon the protein phosphatase itself. Decreasing the con- 
centration of soluble extract by lo-fold yielded a simi- 
lar dose-response pattern (data not shown), suggesting 
that the observed concentration dependence reflected 
an ICsO value in the ,uM range, and was not the conse- 
quence of the titration of a large concentration of pro- 
tein phosphatase by an extremely avid inhibitor, as has 
been observed with some samples of mammalian pro- 
tein phosphatases [9]. Incubation of M. thermophilu 
TM-l in the presence of 10 PM okadaic acid had no 
discernable ffect on either cell growth or methane pro- 
duction. Heparin, a known inhibitor of protein phos- 
phatase 1, also had some inhibitory effect on the enzyme 
(Table I). Experiments with heat-stable protein phos- 
phatase inhibitor-2 yielded mixed results. Although 
substantial inhibition, >90%, of the archaeal protein 
phosphatase was observed when activity toward glyco- 
gen phosphorylase a was measured, little or no inhibi- 
tion could be detected when mixed histones or casein 
were used as substrate (data not shown). 
4. DISCUSSION 
The methanogenic archaeon, A4. thermophila TM-l, 
contained a divalent metal ion-stimulated protein- 
serine phosphatase activity. With respect o many of its 
functional properties, i.e. its stimulation by divalent 
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Fig. 3. Inhibition of IV. thermophila TM-1 protein phosphatase by okadaic acid and related compounds. The DE-52 fraction, 30 pg, was assayed 
under standard conditions using either casein (hatched bars), histones (stippled bars), or glycogen phosphorylase a (open bars), as substrate in the 
presence of the indicated concentrations of the following inhibitors: okadaic acid (left panel), microcystin-LR (center panel), or calyculin A (right 
panel). All results are reported as the activity measured relative to that observed in the absence of inhibitors. 
metal ions, binding to and elution from hydroxylapatite 
and DE-52, apparent substrate affinity, and sensitivity 
to diethylpyrocarbonate, this enzyme strongly resem- 
bled the archaeal protein phosphatases that we had pre- 
viously identified in the extreme acidothermophile, Sul- 
folobus solfataricus [lo], and the halophile, Haloferax 
volcanii [16]. Thus, it would appear that these enzymes 
are members of a common archaeal family of divalent 
metal ion-stimulated protein-serine/threonine phos- 
phatases. These divalent metal ion-stimulated enzymes 
represent he only protein phosphatase activities that we 
have been able to detect thus far in the Archaea using 
a variety of phosphoserine-containing protein sub- 
strates. The protein phosphatase from M. thermophila 
TM-1 different from the other archaeal enzymes, how- 
ever, in that it could be inhibited by okadaic acid, mi- 
crocystin-LR, or calyculin A. 
Okadaic acid [ 171, microcystin-LR [ 181, and calyculin 
A [19] are three naturally occurring toxins, each of 
which has been found to be a highly specific and quite 
potent inhibitor of the type 1/2A/2B superfamily of 
eukaryotic protein-serine/threonine phosphatases. The 
observed selectivity of these compounds for the mem- 
bers of this enzyme superfamily is such that sensitivity 
to them is regarded as their unique functional hallmark 
[8,9]. Thus, it seems both remarkable and highly signif- 
icant that all three of these compounds inhibited a pro- 
tein-serine phosphatase from an organism whose evolu- 
tionary pathway diverged from that of the Eucarya eons 
ago. These three compounds, despite their common in- 
hibitory effects, possess radically different chemical 
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structures: okadaic acid is a polyether fatty acid, micro- 
cystin-LR is a cyclic heptapeptide, and calyculin A is a 
polyhydroxylated fatty acid containing a phospho- 
monoester and two y-amino acids. Yet each of them 
inhibited the M. thermophila TM-l protein-serine phos- 
phatase. While this archaeal enzyme, at least in partially 
purified form, did not exhibit the spectacular nanomo- 
lar affinities for these inhibitors characteristic of the 
type 1 and 2A protein phosphatases, its observed sensi- 
tivity to micromolar concentrations of these com- 
pounds was quite comparable to, if not slightly greater 
than, that exhibited by the other member of this genetic 
superfamily, protein phosphatase 2B. Since these com- 
pounds apparently target a region outside the active site 
of the eukaryotic enzymes [8], it seems unlikely that the 
archaeal protein phosphatase’s ensitivity would have 
arisen as a random by-product of its adaptation to the 
performance of a similar catalytic function. 
The implication of our observations is that inhibition 
by this set of structurally disparate compounds repre- 
sents the functional manifestation of some degree of 
structural homology between this archaeal enzyme and 
a prominent family of eukaryotic protein-serine/threon- 
ine phosphatases. Whether this homology is confined to 
some limited, discrete region or proves to be more 
global in nature must await the determination of the 
sequence of the M. thermophila TM-1 protein phosphat- 
ase. However, it is noteworthy that for those archaeal 
biomolecules that have been cloned and sequenced to 
date, homology with their eukaryotic counterparts has 
proved to be the norm rather than the exception [20]. 
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